ATE489963T1 - Chaperonin-10-immunosuppression - Google Patents

Chaperonin-10-immunosuppression

Info

Publication number
ATE489963T1
ATE489963T1 AT03769073T AT03769073T ATE489963T1 AT E489963 T1 ATE489963 T1 AT E489963T1 AT 03769073 T AT03769073 T AT 03769073T AT 03769073 T AT03769073 T AT 03769073T AT E489963 T1 ATE489963 T1 AT E489963T1
Authority
AT
Austria
Prior art keywords
donor
recipient animal
cpn10
administration
host disease
Prior art date
Application number
AT03769073T
Other languages
English (en)
Inventor
Geoffrey R Hill
Tatjana Banovic
Halle Morton
Alice Christina Cavanagh
Original Assignee
Cbio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cbio Ltd filed Critical Cbio Ltd
Application granted granted Critical
Publication of ATE489963T1 publication Critical patent/ATE489963T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03769073T 2002-11-06 2003-11-06 Chaperonin-10-immunosuppression ATE489963T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002952492A AU2002952492A0 (en) 2002-11-06 2002-11-06 Chaperonin 10 immunosuppression
PCT/AU2003/001467 WO2004041300A1 (en) 2002-11-06 2003-11-06 Chaperonin 10 immunosuppression

Publications (1)

Publication Number Publication Date
ATE489963T1 true ATE489963T1 (de) 2010-12-15

Family

ID=28795882

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03769073T ATE489963T1 (de) 2002-11-06 2003-11-06 Chaperonin-10-immunosuppression

Country Status (16)

Country Link
US (3) US7618935B2 (de)
EP (3) EP2818179A1 (de)
JP (2) JP4716731B2 (de)
KR (1) KR101088740B1 (de)
CN (1) CN100525832C (de)
AT (1) ATE489963T1 (de)
AU (1) AU2002952492A0 (de)
CA (1) CA2505141C (de)
CY (1) CY1110972T1 (de)
DE (1) DE60335202D1 (de)
DK (1) DK1569679T3 (de)
ES (1) ES2351993T3 (de)
NZ (1) NZ540433A (de)
PT (1) PT1569679E (de)
SI (1) SI1569679T1 (de)
WO (1) WO2004041300A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005204979B2 (en) * 2004-01-16 2010-10-21 Cbio Limited Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
JP2007517808A (ja) * 2004-01-16 2007-07-05 キュビオ リミテッド Ｔｏｌｌ様受容体誘導性のサイトカインおよびケモカイン分泌のシャペロニン１０調節
US8036710B2 (en) * 2004-05-07 2011-10-11 Qualcomm, Incorporated Power-efficient multi-antenna wireless device
AU2006269824B2 (en) * 2005-07-11 2012-04-19 Cbio Limited Chaperonin 10-induced immunomodulation
BRPI0613515A2 (pt) * 2005-07-11 2011-01-11 Cbio Ltd imunomodulação induzida por chaperonina 10
KR20080098579A (ko) * 2005-08-31 2008-11-11 씨바이오 리미티드 변형된 샤페로닌 10
KR20080075505A (ko) * 2005-10-20 2008-08-18 씨바이오 리미티드 과민증의 치료 방법
AU2006303826B2 (en) * 2005-10-20 2012-07-19 Cbio Limited Treatment of hypersensitivity
CA2644058C (en) 2006-03-02 2016-08-09 Cbio Limited Regulation of immune responses by modulation of the function of antigen presenting cells
BRPI0911676A2 (pt) * 2008-04-11 2016-11-29 Cbio Ltd polipeptídeo cpn10 isolado, ácido nucléico isolado, construção de expressão, célula hospedeira, anticorpo, composição farmacêutica, método para tratar ou prevenir uma doença, método para modular a sinalização do prr, método para modular a produção e/ou a secreção de um ou mais imunomoduladores, método para inibir a produção e/ou a secreção de um ou mais imunomoduladores, método de identificação de um composto que se liga a um polipeptídeo, método para rastrear um coposto e um ligante de prr e variante funcional, derivado, homólogo, análogo ou fragmento do polipeptídeo
US20110243921A1 (en) * 2010-03-30 2011-10-06 Cbio Limited Prevention and treatment of cutaneous lupus erythematosus
WO2013158959A1 (en) * 2012-04-19 2013-10-24 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of graft-versus-host disease
US9688741B2 (en) 2012-10-23 2017-06-27 Elastagen Pty Ltd Elastic hydrogel
ES2860023T3 (es) 2012-12-10 2021-10-04 Allergan Pharmaceuticals Int Ltd Fabricación de constructos elásticos tridimensionales escalables
EP4316537A3 (de) 2013-08-13 2024-04-10 Allergan Pharmaceuticals International Limited Regenerierung von geschädigtem gewebe

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2233938T3 (es) * 1993-11-30 2005-06-16 The University Of Queensland Chaperonina 10.
CA2176948C (en) * 1993-11-30 2007-05-15 Halle Morton Chaperonin 10
US5989804A (en) * 1994-07-08 1999-11-23 New England Medical Center Hospitals, Inc. E6 binding proteins
AU712606B2 (en) * 1995-08-09 1999-11-11 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US20020142000A1 (en) * 1999-01-15 2002-10-03 Digan Mary Ellen Anti-CD3 immunotoxins and therapeutic uses therefor
EP1218030A4 (de) * 1999-09-10 2004-09-15 Univ Fordham Methoden und zusammensetzungen zur behandlung und prävention von transplantatabstossung durch verwendung von hitzeschockproteinen
GB0028122D0 (en) * 2000-11-17 2001-01-03 St Georges Entpr Ltd Method

Also Published As

Publication number Publication date
EP1569679B1 (de) 2010-12-01
US20120082690A1 (en) 2012-04-05
EP2255824B1 (de) 2014-07-23
DE60335202D1 (en) 2011-01-13
KR101088740B1 (ko) 2011-12-01
US7618935B2 (en) 2009-11-17
DK1569679T3 (da) 2011-01-10
EP1569679A1 (de) 2005-09-07
CA2505141C (en) 2012-07-17
AU2002952492A0 (en) 2002-11-21
CA2505141A1 (en) 2004-05-21
PT1569679E (pt) 2010-12-14
CN100525832C (zh) 2009-08-12
EP2255824A1 (de) 2010-12-01
CY1110972T1 (el) 2015-06-11
SI1569679T1 (sl) 2011-01-31
WO2004041300A1 (en) 2004-05-21
JP2006508099A (ja) 2006-03-09
US8067361B2 (en) 2011-11-29
US20060198834A1 (en) 2006-09-07
NZ540433A (en) 2008-03-28
EP2818179A1 (de) 2014-12-31
CN1735428A (zh) 2006-02-15
EP1569679A4 (de) 2008-02-27
JP4716731B2 (ja) 2011-07-06
KR20050086428A (ko) 2005-08-30
ES2351993T3 (es) 2011-02-14
JP2011088920A (ja) 2011-05-06
US20100099605A1 (en) 2010-04-22

Similar Documents

Publication Publication Date Title
CY1110972T1 (el) Ανοσοκαταστολη με σαπερονινη 10
CY1116107T1 (el) Ενωσεις για χρηση στην αγωγη αυτοανοσων παθησεων, ανοσο-αλλεργικων παθησεων και απορριψης μεταμοσχευσης οργανων ή ιστων
BR0203650A (pt) Estentor de auto-articulação
DE60330468D1 (de) Schweine ohne jegliche expression funktioneller alpha-1,3-galactosyltransferase
ATE463256T1 (de) Mittel zur suppression von transplantat- abstossung
EA200300738A1 (ru) Защита, восстановление и усиление эритропоэтинреактивных клеток, тканей и органов
DK1487431T3 (da) Forebyggelse og/eller behandling af cardiovaskulær sygdom og/eller dermed associeret hjertefejl
PT1404811E (pt) O monóxido de carbono melhora os resultados nos transplantes de tecidos e de orgãos e suprime a apoptose
ES2114888T3 (es) Tratamiento contra el rechazo en el transplante de organos.
EP1676574A3 (de) Verfahren zur Förderung des Überlebens von Zell- und Gewebe-Transplantaten
WO2004039248A3 (en) Repairing or replacing tissues or organs
BR9612821A (pt) Métodos para a prevenção de rejeição de enxerto em transplante e para a produção de uma célula de hospedeiro para terapia genética universal
DK1567171T3 (da) Anvendelse af dextransulfat til behandling af ibmir
NO2019032I1 (no) Treosulfan
WO2004091436A3 (en) Methods and compositions for treating ocular disease
DE60213766D1 (de) Verwendung von beschleunigten lymphozyten zielansteuernden wirkstoffen zur herstellung eines medikaments für die behandlung der verzögertern transplantat-funktion
DE69727948D1 (de) Sordarinderivate
MXPA05004121A (es) Metodos para tratar la enfermedad de ojo reseco con lantibioticos.
DE60023034D1 (en) Cd45 hemmer
ATE238050T1 (de) 4-cyano-4-deformylsordarizin-derivate
BG104258A (en) 4-cyano-4-deformylsordarin derivatives
NO20016326L (no) Anvendelse av proteinet UK 114 for å hindre avstötning av organtransplantatet
HUP0103107A2 (hu) Allogénikus és xenogénikus T-sejtek ex vivo kezelése gp39 antagonistákkal
UA85060C2 (ru) Биологически активная добавка к пище
RU2004128515A (ru) Способ восстановления кожного покрова при комбинированных радиационно-ожоговых поражениях

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1569679

Country of ref document: EP